AEOLUS PHARMACEUTICALS, INC. 4
4 · AEOLUS PHARMACEUTICALS, INC. · Filed Feb 3, 2016
Insider Transaction Report
Form 4
MCMANUS JOHN L
President & CEO
Transactions
- Award
Incentive Stock Option (right to buy)
2014-03-04+250,000→ 250,000 totalExercise: $0.27Exp: 2024-03-04→ Common Stock (250,000 underlying) - Award
Incentive Stock Option (right to buy)
2015-03-04+250,000→ 250,000 totalExercise: $0.27Exp: 2025-03-04→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Option will vest in equal monthly installments over a period of twelve months from the date of grant, provided that the reporting person remains an employee of the Company.